UNSPSC 41131715: Abnormal hemoglobin assay

In this classification an abnormal hemoglobin assay is a device consisting of the reagents, apparatus, instrumentation, and controls necessary to isolate and identify abnormal genetically determined hemoglobin types US FDA regulates Abnormal hemoglobin assay under 21 CFR 864.7415 and under FDA product code GKA.

UNSPSC 41131715 Abnormal hemoglobin assay is a Commodity code that state and local governments actually use to procure laboratory testing services and supplies across a much broader clinical and forensic scope than its nominal title suggests. Recent opportunities show that the code is being applied to offender drug screening and confirmation testing, employment pre-screening physicals with drug and alcohol components, urinalysis for family treatment courts, clozapine level monitoring for psychiatric patients, certified reference materials for forensic toxicology validation, and breath alcohol testing equipment procurement. The issuing-body mix includes county criminal justice and community supervision departments, county human resources and medical services functions, county forensic laboratories, state departments (Oregon), city community college systems, and county health departments. This diversity reflects the code's use across public-safety, occupational-health, and clinical-monitoring workflows rather than abnormal-hemoglobin testing alone.

Recent activity concentrates in Florida (Collin County, Texas; Seminole County, Florida; Clay County, Florida; Collier County, Florida; Pinellas County, Florida), the Pacific Northwest (Benton County, Oregon; State of Oregon), and Nevada (Department of Public Safety). Collin County Community Supervision and Corrections Department posted RFP 2026-327 on July 9, 2026, for offender specimen collection and drug testing services with proposals due July 23, 2026, covering approximately 25,031 tests annually across five-panel and six-panel immunoassay screening with confirmatory LC/MS/MS or GC/MS testing at an estimated contract value of $600,000 over two years with optional three-year renewals. Clay County Board of County Commissioners in Florida issued IFB 25-26054 in February 2026 for physicals and drug testing covering pre-employment physicals, DOT physicals, and fit-for-duty evaluations across 16 line items with a three-year term and two one-year renewal options. City Colleges of Chicago released RFP MWJ2603 on February 18, 2026, for employment screening services encompassing pre-employment drug testing, fitness-for-duty evaluations, criminal background investigations, and Medical Review Officer services for approximately 1,500 to 1,600 candidates annually, with proposals due March 30, 2026, and MBE 25 percent and WBE 7 percent participation requirements. Benton County, Oregon posted RFP SC0200300017156 in June 2026 for urinalysis testing services supporting its Family Treatment Court Program, due July 7, 2026, with a one-year initial term and optional four-year renewals, requiring CLIA certification and twice-weekly testing capability.